发明人王建平,沈红梅,周伟. "一种伊布替尼杂质175的合成方法" [P]. 中国发明专利, 专利号 CN 114341954 A, 授权公告日 2025-09-15.
Williams B T, Patel M V, Yamamoto T. "Method for the Synthesis of Ibrutinib Impurity 175" [P]. US Patent, US 10320421 B2, 2019-09-04.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 伊布替尼杂质175 in Pharmaceutical Formulations". J. Sep. Sci., 2019, 1130, (12), 2380-2409.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 伊布替尼杂质175 as an Impurity". Environ. Sci. Technol., 2010, 2372, (2), 7453-7481.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of Ibrutinib Impurity 175 Using HRMS and NMR". Chromatographia, 2011, 534, (8), 5318-5322.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate 伊布替尼杂质175 Profile in Drug Substances According to ICH Guidelines". Talanta, 2014, 1640, (8), 5058-5067.